Efficacy and Safety of Baricitinib in Neuromyelitis Optica Spectrum Disorders
Clinical trial NCT05792462 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05792462
- Sponsor
- Tianjin Medical University General Hospital
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-15
- Primary completion
- 2027-03-01
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.